Expression of the Non-classical HLA-E, -F, -G Molecules in the Tumour Microenvironment

[1] Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics. CA Cancer J Clin. 2022;72(1):7–33. SiegelRL MillerKD FuchsHE Cancer statistics CA Cancer J Clin. 2022 72 1 7 33 Search in Google Scholar

[2] Cancer 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer. Cancer 2020 Available from: https://www.who.int/news-room/fact-sheets/detail/cancer. Search in Google Scholar

[3] da Silva GBRF, Silva TGA, Duarte RA, et al. Expression of the classical and nonclassical HLA molecules in breast cancer. Int J Breast Cancer. 2013;1–9. da SilvaGBRF SilvaTGA DuarteRA Expression of the classical and nonclassical HLA molecules in breast cancer Int J Breast Cancer. 2013 1 9 Search in Google Scholar

[4] Seliger B, Kloor M, Ferrone S. HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance. Oncoimmunology. 2017;6(2):1–10. SeligerB KloorM FerroneS. HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance Oncoimmunology. 2017 6 2 1 10 Search in Google Scholar

[5] Niranjana AN, Gonzalez F. Non-classical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol. 2012;13(6):579–586. NiranjanaAN GonzalezF. Non-classical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum Nat Immunol. 2012 13 6 579 586 Search in Google Scholar

[6] Bukur J, Jasinski S, Seliger B. The role of classical and non-classical HLA class I antigens in human tumors. Semin Cancer Biol. 2012;22(4):350–358. BukurJ JasinskiS SeligerB. The role of classical and non-classical HLA class I antigens in human tumors Semin Cancer Biol. 2012 22 4 350 358 Search in Google Scholar

[7] Adams EJ, Luoma AM. The adaptable major histocompatibility complex (MHC) fold: Structure and function of nonclassical and mhc class I-like molecules. Annual Review of Immunology. 2013; 31:529–561. AdamsEJ LuomaAM. The adaptable major histocompatibility complex (MHC) fold: Structure and function of nonclassical and mhc class I-like molecules Annual Review of Immunology. 2013 31 529 561 Search in Google Scholar

[8] Robinson J, Barker DJ, Georgiou X, et al. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020; 48(D1):948–955. RobinsonJ BarkerDJ GeorgiouX IPD-IMGT/HLA Database Nucleic Acids Res. 2020 48 D1 948 955 Search in Google Scholar

[9] Morandi F, Pistoia V. Interactions between HLA-G and HLA-E in physiological and pathological conditions. Front Immunol. 2014;5:1–6. MorandiF PistoiaV. Interactions between HLA-G and HLA-E in physiological and pathological conditions Front Immunol. 2014 5 1 6 Search in Google Scholar

[10] Tronik-Le Roux D, Renard J, Vérine J, et al. Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients. Molecular Oncology. 2017;11:561–578. Tronik-Le RouxD RenardJ VérineJ Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients Molecular Oncology. 2017 11 561 578 Search in Google Scholar

[11] Zhang Y, Yu S, Han Y. Human leucocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment. Oncol Lett. 2018;15:699–709. ZhangY YuS HanY. Human leucocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment Oncol Lett. 2018 15 699 709 Search in Google Scholar

[12] Campoli M, Ferrone S. HLA antigen and NK cell activating ligand expression in malignant cells: A story of loss or acquisition. Semin Immunopathol. 2011;33:321–334. CampoliM FerroneS. HLA antigen and NK cell activating ligand expression in malignant cells: A story of loss or acquisition Semin Immunopathol. 2011 33 321 334 Search in Google Scholar

[13] Reimers MS, Engels CC, Putter H, et al. Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: A retrospective cohort study. BMC Cancer. 2014;14(1):1–12. ReimersMS EngelsCC PutterH Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: A retrospective cohort study BMC Cancer. 2014 14 1 1 12 Search in Google Scholar

[14] Borst L, van der Burg SH, van Hall T. The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment. Clin Cancer Res. 2021;26(21):5549–5556. BorstL van der BurgSH van HallT. The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment Clin Cancer Res. 2021 26 21 5549 5556 Search in Google Scholar

[15] Kamiya T, Seow SV, Wong D. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells. J Clin Invest. 2019;129(5):2094–2106. KamiyaT SeowSV WongD. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells J Clin Invest. 2019 129 5 2094 2106 Search in Google Scholar

[16] Wagner B, da Silva Nardi F, Schramm S, et al. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia. Cancer. 2017;123(5):814–823. WagnerB da Silva NardiF SchrammS HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia Cancer. 2017 123 5 814 823 Search in Google Scholar

[17] Lin A, Yan WH. The emerging roles of human leukocyte antigen-F in immune modulation and viral infection. Front Immunol. 2019;10:1–7. LinA YanWH. The emerging roles of human leukocyte antigen-F in immune modulation and viral infection Front Immunol. 2019 10 1 7 Search in Google Scholar

[18] Lin A, Zhang X, Ruan YY, et al. HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer. Lung Cancer. 2011;74(3):504–509. LinA ZhangX RuanYY HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer Lung Cancer. 2011 74 3 504 509 Search in Google Scholar

[19] Loustau M, Anna F, Dréan R, et al. HLA-G neo-expression on tumors. Front Immunol. 2020;11:1–15. LoustauM AnnaF DréanR HLA-G neo-expression on tumors Front Immunol. 2020 11 1 15 Search in Google Scholar

[20] Lin A, Yan WH. Human leukocyte antigen-G (HLA-G) expression in cancers: Roles in immune evasion, metastasis and target for therapy. Mol Med. 2015;21:782–791. LinA YanWH. Human leukocyte antigen-G (HLA-G) expression in cancers: Roles in immune evasion, metastasis and target for therapy Mol Med. 2015 21 782 791 Search in Google Scholar

[21] Rouas-Freiss N, Moreau P, LeMaoult J, et al. The dual role of HLA-G in cancer. J Immunol Res. 2014;1–10. Rouas-FreissN MoreauP LeMaoultJ The dual role of HLA-G in cancer J Immunol Res. 2014 1 10 Search in Google Scholar

[22] Liu L, Wang L, Zhao L, et al. The role of HLA-G in tumor escape: Manipulating the phenotype and function of immune cells. Front Oncol. 2020;10:1–11. LiuL WangL ZhaoL The role of HLA-G in tumor escape: Manipulating the phenotype and function of immune cells Front Oncol. 2020 10 1 11 Search in Google Scholar

[23] Paul P, Rouas-Freiss N, Khalil-Daher I, et al. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA. 1998;95(8):4510–4515. PaulP Rouas-FreissN Khalil-DaherI HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance Proc Natl Acad Sci USA. 1998 95 8 4510 4515 Search in Google Scholar

[24] Derré L, Corvaisier M, Charreau B, et al. Expression and release of HLA-E by melanoma cells and melanocytes: Potential impact on the response of cytotoxic effector cells. J Immunol. 2006; 177(5):3100–3107. DerréL CorvaisierM CharreauB Expression and release of HLA-E by melanoma cells and melanocytes: Potential impact on the response of cytotoxic effector cells J Immunol. 2006 177 5 3100 3107 Search in Google Scholar

[25] Allard M, Oger R, Vignard V, et al. Serum soluble HLA-E in melanoma: A new potential immune-related marker in cancer. PLoS One. 2011;6:6. AllardM OgerR VignardV Serum soluble HLA-E in melanoma: A new potential immune-related marker in cancer PLoS One. 2011 6 6 Search in Google Scholar

[26] Urosevic M, Dummer R. HLA-G in skin cancer: A wolf in sheep’s clothing? Hum Immunol. 2003; 64(11):1073–1080. UrosevicM DummerR. HLA-G in skin cancer: A wolf in sheep’s clothing? Hum Immunol. 2003 64 11 1073 1080 Search in Google Scholar

[27] Urosevic M, Kempf W, Zagrodnik B, et al. HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Clin Exp Dermatol. 2005;30(4):422–425. UrosevicM KempfW ZagrodnikB HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy Clin Exp Dermatol. 2005 30 4 422 425 Search in Google Scholar

[28] Zheng J, Xu C, Chu D, et al. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis. Immunol Lett. 2014;161(1):13–19. ZhengJ XuC ChuD Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis Immunol Lett. 2014 161 1 13 19 Search in Google Scholar

[29] Yie SM, Yang H, Ye SR, et al. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol. 2007;128(6):1002–1009. YieSM YangH YeSR Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma Am J Clin Pathol. 2007 128 6 1002 1009 Search in Google Scholar

[30] Julie B, Charles P, Wisnivesky J. Global epidemiology of lung cancer. Ann Glob Heal. 2019;1–16. JulieB CharlesP WisniveskyJ. Global epidemiology of lung cancer Ann Glob Heal. 2019 1 16 Search in Google Scholar

[31] Yazdi MT, van Riet S, van Schadewijk A, et al. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma. Oncotarget. 2016;7(3):3477–3488. YazdiMT van RietS van SchadewijkA The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma Oncotarget. 2016 7 3 3477 3488 Search in Google Scholar

[32] Llovet J, Kelley R, Villanueva A. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7(6):1–28. LlovetJ KelleyR VillanuevaA. Hepatocellular carcinoma Nat Rev Dis Prim. 2021 7 6 1 28 Search in Google Scholar

[33] Xu Y, Han H, Zhang F. Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma. Oncol Lett. 2015;9:300–304. XuY HanH ZhangF. Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma Oncol Lett. 2015 9 300 304 Search in Google Scholar

[34] Crew K, Neugut A. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–362. CrewK NeugutA. Epidemiology of gastric cancer World J Gastroenterol. 2006 12 3 354 362 Search in Google Scholar

[35] Murdaca G, Calamaro P, Lantieri F, et al. HLA-G expression in gastric carcinoma: Clinicopathological correlations and prognostic impact. Virchows Arch. 2018;473(4):425–433. MurdacaG CalamaroP LantieriF HLA-G expression in gastric carcinoma: Clinicopathological correlations and prognostic impact Virchows Arch. 2018 473 4 425 433 Search in Google Scholar

[36] Zeestraten ECM, Reimers MS, Saadatmand S, et al. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. Br J Cancer. 2014;110(2):459–468. ZeestratenECM ReimersMS SaadatmandS Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients Br J Cancer. 2014 110 2 459 468 Search in Google Scholar

[37] Guo ZY, Lv YG, Wang L, et al. Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients. Cell Immunol. 2015;293(1):10–16. GuoZY LvYG WangL Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients Cell Immunol. 2015 293 1 10 16 Search in Google Scholar

[38] Ye S, Yang H, Li K. Human leukocyte antigen G expression: As a significant prognostic indicator for patients with colorectal cancer. Mod Pathol. 2007;20:375–383. YeS YangH LiK. Human leukocyte antigen G expression: As a significant prognostic indicator for patients with colorectal cancer Mod Pathol. 2007 20 375 383 Search in Google Scholar

[39] Breastcancer.org. https://www.breastcancer.org/symptoms/understand_bc/statistics. Breastcancer.org https://www.breastcancer.org/symptoms/understand_bc/statistics. Search in Google Scholar

[40] Menier C, Rouas-Freiss N, Favier B, et al. Recent advances on the non-classical major histocompatibility complex class i HLA-G molecule. Tissue Antigens. 2010;75(3):201–206. MenierC Rouas-FreissN FavierB Recent advances on the non-classical major histocompatibility complex class i HLA-G molecule Tissue Antigens. 2010 75 3 201 206 Search in Google Scholar

[41] de Kruijf EM, Sajet A, van Nes JGH, et al. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol. 2010;185(12):7452–7459. de KruijfEM SajetA van NesJGH HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients J Immunol. 2010 185 12 7452 7459 Search in Google Scholar

[42] Harada A, Ishigami S, Kijima Y, et al. Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer. Pathol Int. 2015;65(11):569–574. HaradaA IshigamiS KijimaY Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer Pathol Int. 2015 65 11 569 574 Search in Google Scholar

[43] Gooden M, Lampen M, Jordanova ES, et al. HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8 + T lymphocytes. Proc Natl Acad Sci USA. 2011;108(26):10656–10661. GoodenM LampenM JordanovaES HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8 + T lymphocytes Proc Natl Acad Sci USA. 2011 108 26 10656 10661 Search in Google Scholar

[44] Van Esch EMG, Tummers B, Baartmans V, et al. Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy. Int J Cancer. 2014;135(4):830–842. Van EschEMG TummersB BaartmansV Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy Int J Cancer. 2014 135 4 830 842 Search in Google Scholar

[45] Centers for Disease Control and Prevention. Ovarian cancer statistics. https://www.cdc.gov/cancer/ovarian/statistics/. Centers for Disease Control and Prevention Ovarian cancer statistics https://www.cdc.gov/cancer/ovarian/statistics/. Search in Google Scholar

[46] Babay W, Ben Yahia H, Boujelbene N, et al. Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma. Hum Immunol. 2018;79(6):463–470. BabayW Ben YahiaH BoujelbeneN Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma Hum Immunol. 2018 79 6 463 470 Search in Google Scholar

[47] Kanevskiy L, Erokhina S, Kobyzeva P, et al. Dimorphism of HLA-E and its disease association. Int J Mol Sci. 2019;20(21):1–16. KanevskiyL ErokhinaS KobyzevaP Dimorphism of HLA-E and its disease association Int J Mol Sci. 2019 20 21 1 16 Search in Google Scholar

[48] Guan J, Xie L, Luo X. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: Hormone receptors in risk stratification. Gynecol Oncol. 2019;30(1):1–14. GuanJ XieL LuoX. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: Hormone receptors in risk stratification Gynecol Oncol. 2019 30 1 1 14 Search in Google Scholar

[49] Bijen CBM, Bantema-Joppe EJ, De Jong RA, et al. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. Int J Cancer. 2010;126(6):1417–1427. BijenCBM Bantema-JoppeEJ De JongRA The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer Int J Cancer. 2010 126 6 1417 1427 Search in Google Scholar

[50] Haque A, Banik NL, Ray SK. Molecular alterations in glioblastoma: Potential targets for immunotherapy. Prog Mol Bio and Trans Sci. 2011;98:187–234 HaqueA BanikNL RaySK. Molecular alterations in glioblastoma: Potential targets for immunotherapy Prog Mol Bio and Trans Sci. 2011 98 187 234 Search in Google Scholar

[51] Wu Z, Liang J, Wang Z, et al. HLA-E expression in diffuse glioma: Relationship with clinicopathological features and patient survival. BMC Neurol. 2020;20(1):1–7. WuZ LiangJ WangZ HLA-E expression in diffuse glioma: Relationship with clinicopathological features and patient survival BMC Neurol. 2020 20 1 1 7 Search in Google Scholar

[52] Bukova M, Kluckova K, Kozak J. HLA-G 14 bp ins/del polymorphism, plasma level of soluble HLA-G and association with IL-6/IL-10 ratio and survival of glioma patients. Prepr. 2021;1–23. BukovaM KluckovaK KozakJ. HLA-G 14 bp ins/del polymorphism, plasma level of soluble HLA-G and association with IL-6/IL-10 ratio and survival of glioma patients Prepr. 2021 1 23 Search in Google Scholar

[53] Wagner B, Nardi F, Schramm S. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia. Wiley Online Libr. 2016;814–823. WagnerB NardiF SchrammS. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia Wiley Online Libr. 2016 814 823 Search in Google Scholar

[54] Nückel H, Rebmann V, Dürig J, et al. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood. 2005;105(4):1694–1698. NückelH RebmannV DürigJ HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia Blood. 2005 105 4 1694 1698 Search in Google Scholar

[55] Yan WH, Lin A, Chen BG, et al. Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia. J Cell Mol Med. 2008;12(3):889–898. YanWH LinA ChenBG Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia J Cell Mol Med. 2008 12 3 889 898 Search in Google Scholar

[56] Sebti Y, Le Maux A, Gros F, et al. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br J Haematol. 2007;138(2):202–212. SebtiY Le MauxA GrosF Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders Br J Haematol. 2007 138 2 202 212 Search in Google Scholar

[57] Jesionek-Kupnicka D, Bojo M, Prochorec-Sobieszek M. HLA-G and MHC class II protein expression in diffuse large B-cell lymphoma. Blood. 2016;64(3):225–240. Jesionek-KupnickaD BojoM Prochorec-SobieszekM. HLA-G and MHC class II protein expression in diffuse large B-cell lymphoma Blood. 2016 64 3 225 240 Search in Google Scholar

[58] Diepstra A, Poppema S, Boot M, et al. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma. Tissue Antigens. 2008;71(3):219–226. DiepstraA PoppemaS BootM HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma Tissue Antigens. 2008 71 3 219 226 Search in Google Scholar

[59] Caocci G, Greco M, Fanni D, et al. HLA-G expression and role in advanced-stage classical Hodgkin lymphoma. Eur J Histochem. 2016;60(2):1–6. CaocciG GrecoM FanniD HLA-G expression and role in advanced-stage classical Hodgkin lymphoma Eur J Histochem. 2016 60 2 1 6 Search in Google Scholar

[60] Martin P, Krsnik I, Navarro B. HLA allele E*01:01 is associated with a reduced risk of EBV-related classical Hodgkin lymphoma independently of HLA-A*01/*02. PLoS One. 2015;1–13. MartinP KrsnikI NavarroB. HLA allele E*01:01 is associated with a reduced risk of EBV-related classical Hodgkin lymphoma independently of HLA-A*01/*02 PLoS One. 2015 1 13 Search in Google Scholar

[61] Amiot L, Ferrone S, Grosse-Wilde H, et al. Biology of HLA-G in cancer: A candidate molecule for therapeutic intervention? Cell Mol Life Sci. 2011;68(3):417–431. AmiotL FerroneS Grosse-WildeH Biology of HLA-G in cancer: A candidate molecule for therapeutic intervention? Cell Mol Life Sci. 2011 68 3 417 431 Search in Google Scholar

[62] Adolf IC, Almars A, Dharsee N, et al. HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine. Genes Dis. 2021;9(5):1220–1233. AdolfIC AlmarsA DharseeN HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine Genes Dis. 2021 9 5 1220 1233 Search in Google Scholar

[63] Belén Palma M, Tronik-Le Roux D, Amín G, et al. HLA-G gene editing: A novel therapeutic alternative in cancer immunotherapy. bioRxiv. 2021. https://doi.org/10.1101/2021.01.21.427294. Belén PalmaM Tronik-Le RouxD AmínG HLA-G gene editing: A novel therapeutic alternative in cancer immunotherapy bioRxiv 2021 https://doi.org/10.1101/2021.01.21.427294. Search in Google Scholar